Analysis of Risk Factors for Low Bone Mineral Density in Inflammatory Bowel Disease

Abstract

Background/Aim: Several risk factors have been suggested for osteoporosis which frequently occurs in inflammatory bowel disease (IBD) patients. We studied prevalence and risk factors for reduced bone mineral density (BMD) in IBD patients at the University Hospital of Zürich, Switzerland. Methods: The BMD was determined by dual-energy X-ray absorptiometry at the lumbar spine and femoral neck in 88 IBD patients (55 with Crohn’s disease, 30 with ulcerative colitis, and 3 with indeterminate colitis). Z scores were obtained by comparison with age- and sex-matched normal values, and T scores by comparison with sex-matched healthy young adults. Osteopenia and osteoporosis were defined according to the WHO guidelines. Predictive factors for BMD were analyzed by group comparison and stepwise regression analysis. Results: Osteopenia was present in 43% of the patients at the lumbar spine and in 42% of them at the femoral neck. Osteoporosis was present in 14% of the patients at the lumbar spine and in 5% of them at the femoral neck. At the lumbar spine, stepwise regression analysis showed that body mass index, age, number of bowel resections, topic steroids, and azathioprine correlated with the Z scores. Cumulative steroid dose, topic steroids, age and bowel resection were found to be predictors for a pathological T score. At the femoral neck, regression analysis showed that body mass index, age, topic steroids, and azathioprine correlated with the Z scores. Only a low body mass index was a significant predictor for pathological femoral T scores. Conclusions: Osteopenia and osteoporosis are commonly found in IBD patients. Steroid treatment and bowel resection were significant risk factors for osteoporosis of the lumbar spine. However, disease-inherent factors also appear to confer a major risk, indicating that the BMD should be determined in all IBD patients, irrespective of steroid treatment.

Relationship between Bone Mineral Density and Clinical Features in Patients with Inflammatory Bowel Disease: A Local Study in Turkish Population

“…It is unlikely that steroid use is the only risk factor in patients who are taking high-dose steroids; disease activity and malabsorption are also more pronounced in these patients. 14 No relationship was found between the use of a cumulative steroid dose of 2 g for ≥ 1 month and BMD in patients in the present study. This is probably because the steroid dose used was low.…”

“…13 In a group of CD patients with a mean age of 40 years, 15% had osteoporosis and 50% had osteopenia. 14 The risk of osteoporosis was higher in those who received the CD diagnosis before the age of 18 years.…”

Bone Mineral Density Changes in Patients with Spondyloarthropathies

“…Data on statistically significant BMD reduction in entire skeleton of EnA patients compared with the control group was published by several authors. (Frei, 2006;Reffitt, 2003). J. Grisar and colleagues investigated bone metabolism markers and BMD of AS, PsA and ReA patients.…”

Osteoporosis in Gastrointestinal Diseases

“…The risk of bone fracture in the course of Crohn's disease was slightly higher than in ulcerative colitis [9]. Risk factors of osteoporosis in Crohn's disease, according to Frei [10] include: high daily dose of GCs and prolonged treatment period, young age at the time of diagnosis (usually a higher disease activity), history of bowel resection, the use of azathioprine as well as low body weight. A major and common problem in patients with IBD is vitamin D deficiency.…”